| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |